Alex Ralph is the Chief Business Correspondent for The Times, focusing on national business news in the United Kingdom. With a keen eye for financial markets and corporate developments, Alex covers a wide range of topics including mergers and acquisitions, regulatory changes, and the performance of major companies.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United Kingdom (National)
Not enough data
Alex Ralph's coverage primarily focuses on the UK's healthcare and pharmaceutical industries, with a significant emphasis on financial analysis. She also covers technology, finance, telecom, and energy to a lesser extent.
Given her focus, she would likely be interested in pitches related to financial performance within the healthcare sector or timely investment analysis specific to UK-based pharmaceutical companies. Pitches offering insights into government announcements affecting these industries could also be of interest.
For those looking to reach out to Alex Ralph for potential news coverage or commentary opportunities, it is important that they provide data-backed insights related to the pharmaceutical industry or offer perspectives on how specific events impact the business and financial aspects of healthcare companies in the United Kingdom.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Company pledges full co-operation with the authorities
By: Oliver Wright, Alex Ralph
Food and drink bosses say an ‘avalanche’ of extra costs may force them to cut investment and jobs and pass on price increases to customers
Genetic sequencing company will partner with health agencies to improve the country’s prepardeness for another pandemic
Chief executive seeks to carry on business as usual following the detention of its China president and a turbulent week for the share price
By: Alex Ralph, Steven Swinford
Labour’s budget measures could push private providers out of business without higher rates from councils, say operators
Pascal Soriot says the pharmaceutical giant ‘will fully co-operate with the authorities’ if requested after a share sell-off wiped £17bn off its value last week
By: Richard Fletcher, Alex Ralph, Steven Swinford
In opposition Rachel Reeves won the backing of some of Britain’s most powerful executives, but her tax raid in the budget has led to dire warnings of trouble ahead
By: Alex Ralph, Steven Swinford, Richard Fletcher
Frustrated business leaders say speed and scale of Rachel Reeves reforms will slow the economy
The vaccine sceptic’s nomination by Donald Trump for head of the US health department has unsettled investors in the pharmaceutical sector
Acquisition of International Distribution Services by Daniel Kretinsky’s group will be reviewed by the newly elected parliament’s business select committee
(833) 317-6278 
